Literature DB >> 7763235

The role of protein kinase in human synovial fibroblast growth.

K Migita1, K Eguchi, T Tsukada, Y Kawabe, T Aoyagi, S Nagataki.   

Abstract

The histological features of rheumatoid arthritis (RA) consist of overgrowth of synovial cells. Several growth factors that cause synovial hyperplasia have been identified in RA synovium. The basic-fibroblast growth factor (b-FGF), representing one of these growth factors, may play an important role in the pathogenesis of RA. We examined the b-FGF-mediated intracellular signal pathway involved in synovial cell growth. b-FGF-induced synovial cell growth was inhibited by protein tyrosine kinase (PTK) inhibitors, herbimycin A and genistein, but not by H7 that inhibits protein kinase C (PKC). Stimulation of synovial cells with b-FGF resulted in tyrosine phosphorylation of cellular proteins and MAP kinase activation. Our results also demonstrated that b-FGF-mediated activation of MAP kinase was inhibited by herbimycin A indicating that protein tyrosine kinase may be involved in the activation of MAP kinase in human synovial cells. However, inhibition of b-FGF-mediated MAP kinase activation by PKC downregulation did not occur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763235     DOI: 10.1006/bbrc.1995.1765

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Association of rheumatoid arthritis risk with EGFR genetic polymorphisms in Taiwan's Han Chinese population.

Authors:  Sui-Foon Lo; Lei Wan; Hsiu-Chen Lin; Chung-Ming Huang; Shih-Yin Chen; Su-Ching Liu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2011-05-21       Impact factor: 2.631

2.  Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.

Authors:  T Pap; J K Franz; K M Hummel; E Jeisy; R Gay; S Gay
Journal:  Arthritis Res       Date:  2000

3.  Proinflammatory role of amphiregulin, an epidermal growth factor family member whose expression is augmented in rheumatoid arthritis patients.

Authors:  Shoji Yamane; Satoru Ishida; Yukie Hanamoto; Ken-Ichi Kumagai; Riako Masuda; Konagi Tanaka; Noriyuki Shiobara; Noriko Yamane; Toshihito Mori; Takuo Juji; Naoshi Fukui; Tsunetoshi Itoh; Takahiro Ochi; Ryuji Suzuki
Journal:  J Inflamm (Lond)       Date:  2008-04-27       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.